Global CRISPR-Based Therapeutics Market Size, Status and Forecast 2022

SKU ID : QYR-19730228 | Publishing Date : 16-Dec-2021 | No. of pages : 105

Detailed TOC of Global CRISPR-Based Therapeutics Market Size, Status and Forecast 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Genome Editing
        1.2.3 Genetic Engineering
        1.2.4 gRNA Database/Gene Librar
        1.2.5 CRISPR Plasmid
        1.2.6 Human Stem Cells
        1.2.7 Genetically Modified Organisms/Crops
        1.2.8 Cell Line Engineering
    1.3 Market by Application
        1.3.1 Global CRISPR-Based Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Biotechnology Companies
        1.3.3 Pharmaceutical Companies
        1.3.4 Academic Institutes
        1.3.5 Research and Development Institutes
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global CRISPR-Based Therapeutics Market Perspective (2016-2027)
    2.2 CRISPR-Based Therapeutics Growth Trends by Regions
        2.2.1 CRISPR-Based Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 CRISPR-Based Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 CRISPR-Based Therapeutics Industry Dynamic
        2.3.1 CRISPR-Based Therapeutics Market Trends
        2.3.2 CRISPR-Based Therapeutics Market Drivers
        2.3.3 CRISPR-Based Therapeutics Market Challenges
        2.3.4 CRISPR-Based Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top CRISPR-Based Therapeutics Players by Revenue
        3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by CRISPR-Based Therapeutics Revenue
    3.4 Global CRISPR-Based Therapeutics Market Concentration Ratio
        3.4.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2020
    3.5 CRISPR-Based Therapeutics Key Players Head office and Area Served
    3.6 Key Players CRISPR-Based Therapeutics Product Solution and Service
    3.7 Date of Enter into CRISPR-Based Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR-Based Therapeutics Breakdown Data by Type
    4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2022-2027)

5 CRISPR-Based Therapeutics Breakdown Data by Application
    5.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America CRISPR-Based Therapeutics Market Size (2016-2027)
    6.2 North America CRISPR-Based Therapeutics Market Size by Type
        6.2.1 North America CRISPR-Based Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America CRISPR-Based Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America CRISPR-Based Therapeutics Market Size by Type (2016-2027)
    6.3 North America CRISPR-Based Therapeutics Market Size by Application
        6.3.1 North America CRISPR-Based Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America CRISPR-Based Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America CRISPR-Based Therapeutics Market Size by Application (2016-2027)
    6.4 North America CRISPR-Based Therapeutics Market Size by Country
        6.4.1 North America CRISPR-Based Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America CRISPR-Based Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe CRISPR-Based Therapeutics Market Size (2016-2027)
    7.2 Europe CRISPR-Based Therapeutics Market Size by Type
        7.2.1 Europe CRISPR-Based Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe CRISPR-Based Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe CRISPR-Based Therapeutics Market Size by Type (2016-2027)
    7.3 Europe CRISPR-Based Therapeutics Market Size by Application
        7.3.1 Europe CRISPR-Based Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe CRISPR-Based Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe CRISPR-Based Therapeutics Market Size by Application (2016-2027)
    7.4 Europe CRISPR-Based Therapeutics Market Size by Country
        7.4.1 Europe CRISPR-Based Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe CRISPR-Based Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific CRISPR-Based Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type
        8.2.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application
        8.3.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region
        8.4.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America CRISPR-Based Therapeutics Market Size (2016-2027)
    9.2 Latin America CRISPR-Based Therapeutics Market Size by Type
        9.2.1 Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America CRISPR-Based Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America CRISPR-Based Therapeutics Market Size by Application
        9.3.1 Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America CRISPR-Based Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America CRISPR-Based Therapeutics Market Size by Country
        9.4.1 Latin America CRISPR-Based Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America CRISPR-Based Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa CRISPR-Based Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type
        10.2.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application
        10.3.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country
        10.4.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Caribou Biosciences
        11.1.1 Caribou Biosciences Company Details
        11.1.2 Caribou Biosciences Business Overview
        11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction
        11.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.1.5 Caribou Biosciences Recent Development
    11.2 Addgene
        11.2.1 Addgene Company Details
        11.2.2 Addgene Business Overview
        11.2.3 Addgene CRISPR-Based Therapeutics Introduction
        11.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.2.5 Addgene Recent Development
    11.3 CRISPR THERAPEUTICS
        11.3.1 CRISPR THERAPEUTICS Company Details
        11.3.2 CRISPR THERAPEUTICS Business Overview
        11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction
        11.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.3.5 CRISPR THERAPEUTICS Recent Development
    11.4 Merck KGaA
        11.4.1 Merck KGaA Company Details
        11.4.2 Merck KGaA Business Overview
        11.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction
        11.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.4.5 Merck KGaA Recent Development
    11.5 Mirus Bio LLC
        11.5.1 Mirus Bio LLC Company Details
        11.5.2 Mirus Bio LLC Business Overview
        11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction
        11.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.5.5 Mirus Bio LLC Recent Development
    11.6 Editas Medicine
        11.6.1 Editas Medicine Company Details
        11.6.2 Editas Medicine Business Overview
        11.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction
        11.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.6.5 Editas Medicine Recent Development
    11.7 Takara Bio USA
        11.7.1 Takara Bio USA Company Details
        11.7.2 Takara Bio USA Business Overview
        11.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction
        11.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.7.5 Takara Bio USA Recent Development
    11.8 Thermo Fisher Scientific
        11.8.1 Thermo Fisher Scientific Company Details
        11.8.2 Thermo Fisher Scientific Business Overview
        11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction
        11.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.8.5 Thermo Fisher Scientific Recent Development
    11.9 Horizon Discovery Group
        11.9.1 Horizon Discovery Group Company Details
        11.9.2 Horizon Discovery Group Business Overview
        11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction
        11.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.9.5 Horizon Discovery Group Recent Development
    11.10 Intellia Therapeutics
        11.10.1 Intellia Therapeutics Company Details
        11.10.2 Intellia Therapeutics Business Overview
        11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction
        11.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.10.5 Intellia Therapeutics Recent Development
    11.11 GE Healthcare Dharmacon
        11.11.1 GE Healthcare Dharmacon Company Details
        11.11.2 GE Healthcare Dharmacon Business Overview
        11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction
        11.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2016-2021)
        11.11.5 GE Healthcare Dharmacon Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global CRISPR-Based Therapeutics Market Size, Status and Forecast 2022

List of Tables
    Table 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Genome Editing
    Table 3. Key Players of Genetic Engineering
    Table 4. Key Players of gRNA Database/Gene Librar
    Table 5. Key Players of CRISPR Plasmid
    Table 6. Key Players of Human Stem Cells
    Table 7. Key Players of Genetically Modified Organisms/Crops
    Table 8. Key Players of Cell Line Engineering
    Table 9. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global CRISPR-Based Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global CRISPR-Based Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global CRISPR-Based Therapeutics Market Share by Regions (2016-2021)
    Table 13. Global CRISPR-Based Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global CRISPR-Based Therapeutics Market Share by Regions (2022-2027)
    Table 15. CRISPR-Based Therapeutics Market Trends
    Table 16. CRISPR-Based Therapeutics Market Drivers
    Table 17. CRISPR-Based Therapeutics Market Challenges
    Table 18. CRISPR-Based Therapeutics Market Restraints
    Table 19. Global CRISPR-Based Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global CRISPR-Based Therapeutics Market Share by Players (2016-2021)
    Table 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2020)
    Table 22. Ranking of Global Top CRISPR-Based Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by CRISPR-Based Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players CRISPR-Based Therapeutics Product Solution and Service
    Table 26. Date of Enter into CRISPR-Based Therapeutics Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2016-2021)
    Table 30. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global CRISPR-Based Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2016-2021)
    Table 34. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 41. North America CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 42. Europe CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 47. Europe CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2016-2021) & (US$ Million)
    Table 53. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2022-2027) & (US$ Million)
    Table 54. Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 59. Latin America CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
    Table 65. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
    Table 66. Caribou Biosciences Company Details
    Table 67. Caribou Biosciences Business Overview
    Table 68. Caribou Biosciences CRISPR-Based Therapeutics Product
    Table 69. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 70. Caribou Biosciences Recent Development
    Table 71. Addgene Company Details
    Table 72. Addgene Business Overview
    Table 73. Addgene CRISPR-Based Therapeutics Product
    Table 74. Addgene Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 75. Addgene Recent Development
    Table 76. CRISPR THERAPEUTICS Company Details
    Table 77. CRISPR THERAPEUTICS Business Overview
    Table 78. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product
    Table 79. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 80. CRISPR THERAPEUTICS Recent Development
    Table 81. Merck KGaA Company Details
    Table 82. Merck KGaA Business Overview
    Table 83. Merck KGaA CRISPR-Based Therapeutics Product
    Table 84. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 85. Merck KGaA Recent Development
    Table 86. Mirus Bio LLC Company Details
    Table 87. Mirus Bio LLC Business Overview
    Table 88. Mirus Bio LLC CRISPR-Based Therapeutics Product
    Table 89. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 90. Mirus Bio LLC Recent Development
    Table 91. Editas Medicine Company Details
    Table 92. Editas Medicine Business Overview
    Table 93. Editas Medicine CRISPR-Based Therapeutics Product
    Table 94. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 95. Editas Medicine Recent Development
    Table 96. Takara Bio USA Company Details
    Table 97. Takara Bio USA Business Overview
    Table 98. Takara Bio USA CRISPR-Based Therapeutics Product
    Table 99. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Takara Bio USA Recent Development
    Table 101. Thermo Fisher Scientific Company Details
    Table 102. Thermo Fisher Scientific Business Overview
    Table 103. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 104. Thermo Fisher Scientific Recent Development
    Table 105. Horizon Discovery Group Company Details
    Table 106. Horizon Discovery Group Business Overview
    Table 107. Horizon Discovery Group CRISPR-Based Therapeutics Product
    Table 108. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 109. Horizon Discovery Group Recent Development
    Table 110. Intellia Therapeutics Company Details
    Table 111. Intellia Therapeutics Business Overview
    Table 112. Intellia Therapeutics CRISPR-Based Therapeutics Product
    Table 113. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 114. Intellia Therapeutics Recent Development
    Table 115. GE Healthcare Dharmacon Company Details
    Table 116. GE Healthcare Dharmacon Business Overview
    Table 117. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product
    Table 118. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
    Table 119. GE Healthcare Dharmacon Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CRISPR-Based Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Genome Editing Features
    Figure 3. Genetic Engineering Features
    Figure 4. gRNA Database/Gene Librar Features
    Figure 5. CRISPR Plasmid Features
    Figure 6. Human Stem Cells Features
    Figure 7. Genetically Modified Organisms/Crops Features
    Figure 8. Cell Line Engineering Features
    Figure 9. Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2027
    Figure 10. Biotechnology Companies Case Studies
    Figure 11. Pharmaceutical Companies Case Studies
    Figure 12. Academic Institutes Case Studies
    Figure 13. Research and Development Institutes Case Studies
    Figure 14. CRISPR-Based Therapeutics Report Years Considered
    Figure 15. Global CRISPR-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global CRISPR-Based Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global CRISPR-Based Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 18. Global CRISPR-Based Therapeutics Market Share by Regions (2022-2027)
    Figure 19. Global CRISPR-Based Therapeutics Market Share by Players in 2020
    Figure 20. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2020
    Figure 22. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 23. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 24. North America CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America CRISPR-Based Therapeutics Market Share by Type (2016-2027)
    Figure 26. North America CRISPR-Based Therapeutics Market Share by Application (2016-2027)
    Figure 27. North America CRISPR-Based Therapeutics Market Share by Country (2016-2027)
    Figure 28. United States CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe CRISPR-Based Therapeutics Market Share by Type (2016-2027)
    Figure 32. Europe CRISPR-Based Therapeutics Market Share by Application (2016-2027)
    Figure 33. Europe CRISPR-Based Therapeutics Market Share by Country (2016-2027)
    Figure 34. Germany CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific CRISPR-Based Therapeutics Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific CRISPR-Based Therapeutics Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2016-2027)
    Figure 44. China CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America CRISPR-Based Therapeutics Market Share by Type (2016-2027)
    Figure 52. Latin America CRISPR-Based Therapeutics Market Share by Application (2016-2027)
    Figure 53. Latin America CRISPR-Based Therapeutics Market Share by Country (2016-2027)
    Figure 54. Mexico CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa CRISPR-Based Therapeutics Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa CRISPR-Based Therapeutics Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa CRISPR-Based Therapeutics Market Share by Country (2016-2027)
    Figure 60. Turkey CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 64. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 65. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 66. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 67. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 68. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 69. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 70. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 71. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 72. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 73. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed

Keyplayers in Global CRISPR-Based Therapeutics Market Size, Status and Forecast 2022

Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon